Set Appointment

Value Creation Investors

RCP Venture Capital is an emerging fund built on the foundation of deep commercialization expertise. We partner with innovative biotech and medical device companies—particularly those advancing through clinical development—to accelerate their path to market and maximize value creation. Leveraging the experience and networks of Rapid Commercialization Partners, our venture arm combines strategic capital with hands-on support in market access, regulatory, medical affairs, and commercial strategy. With a flexible investment model that includes both a core venture fund and SPV structures, RCP Venture Capital is uniquely positioned to connect high-potential companies with the capital, insights, and partnerships they need to thrive.

Learn More
Contact Us

Commercialization Expertise

At RCP Venture Capital, we combine investment with hands-on commercialization expertise to help portfolio companies reach their next milestone. Our team brings deep experience in Market Access, Medical Affairs, Regulatory, and core commercial strategy, giving companies the operational edge to accelerate approvals, build credibility, and drive adoption. By pairing capital with proven execution, we help transform clinical-stage innovation into commercial success.

More About Us

25+

Years of experience

Areas of Expertise

We bring deep experience across some of the most challenging and high-impact areas of healthcare. Our targets span rare and orphan diseases, oncology, neurology, and cardiology, as well as next-generation medical devices such as implantables, diagnostics, and digital health platforms. We have worked alongside companies developing novel therapeutics, advanced biologics, cell and gene therapies, drug-device combinations, and precision diagnostics—each requiring thoughtful strategy, operational know-how, and targeted commercialization pathways. This breadth allows us to partner effectively with innovators tackling the toughest clinical and market hurdles.

Therapeutics

We partner with companies developing novel drugs, biologics, and advanced therapies, with a strong track record in rare and orphan diseases, oncology, neurology, and cardiology

Diagnostics

We support innovators creating precision diagnostics, companion tests, and advanced biomarker platforms that enable earlier detection and smarter clinical decisions.

Medical Device

Our experience spans implantables, surgical tools, and combination products, helping device companies navigate complex regulatory and adoption pathways.

Health Tech

We work with digital health, AI-enabled platforms, and connected care solutions that are transforming how patients, providers, and payers engage with healthcare.

View All Services
Christina J. Ansted

Managing Partner

Michael C. Janes

Managing Partner

Meet Our Managing Partners

Christina brings deep biotech expertise from a career spent advancing innovative therapies across the life sciences industry. Michael complements this with extensive operational and commercialization experience, helping companies scale and execute effectively. Together, they combine scientific insight and hands-on execution to guide RCP Venture Capital’s portfolio to success.

deep expertise in commercializing therapies

guiding companies through critical growth stages

View All Team

What Our Partners Say

Companies working with RCP Venture Capital consistently highlight how our approach helps them shift their commercial focus earlier in development, positioning them more effectively with investors and strategic partners. By combining capital with practical commercialization expertise, we help founders anticipate market access, regulatory, and adoption challenges well before launch. This early, integrated perspective gives portfolio companies the confidence and credibility to engage investors and partners with a clear path to value creation.

In my view, RCPVC plays a critical role in bridging the gap between scientific innovation and commercial viability. Their ability to guide neurologically focused therapeutics, devices, and digital health platforms toward meaningful inflection points not only accelerates company growth but also brings much-needed innovations closer to patients who urgently need them.

Jonas

Partner

RCPVC combines financial investment with hands-on commercialization expertise, which is rare in the venture space. Their team understands the nuances of regulatory pathways, clinical trial design in CNS indications, and the importance of early market access strategy to secure both investor confidence and patient impact

Marry

Parnter

Keep Updated With Conferences and News

we are active participants in the global life sciences investment community. Our team regularly attends and speaks at leading investor conferences, industry forums, and partnering events, creating opportunities to connect portfolio companies with the right capital sources and strategic collaborators. By staying present and engaged at these gatherings, we not only expand our own network but also open doors for our partners—helping them build visibility, credibility, and momentum in front of the investors and decision-makers who matter most.